prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, (Age: F. Pathologic Interpretation: A. SENTINEL NODE NO.1 AXILLA CONTENT. - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. B. RIGHT BREAST (SHORT STITCH SUPERIOR LONG STITCH LATERAL): - Invasive lobular carcinoma, intermediate nuclear grade, with formation of two dominant tumoral masses, 4,0 cm and. 1.0 cm. - The tumor invades the dermal skin. - Lymphovascular spaces invasion is identified. - Specimen margin is negative for tumor. - Metastatic carcinoma to two of eight lymph nodes (/2/8). C. SENTINEL NODE NO. 2 AXILLA COUNT. - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. Tumor Summary: Specimen: - Total breast. Procedure: - Total mastectomy. Lymph Node Sampling: - Sentinel lymph node. - Axillary dissection. Specimen Integrity: - Single intact specimen. Specimen Size: - Greatest dimension: 21 cm. Additional dimension: 16 x 4 cm. Laterality: - Right. Tumor Site: - Lower outer quadrant. - Upper inner quadrant. - Lower inner quadrant. Tumor Size: - Greatest dimension of largest focus of invasion over 0.1 cm: 4 cm. - Additional dimensions: 1 x 1 cm. Tumor Focality: - Multiple focus of invasive carcinoma. Macroscopic and Microscopic Extent of tumor: - Skin: Satellite skin foci of invasive carcinoma are present. Lobular Carcinoma IN Situ (LCIS): - Present. Histologic Type: - Invasive lobular carcinoma. Histologic Grade: - Overall Grade: Grade 2. Margins: - Margins uninvolved by invasive carcinoma. Lymph-Vascular Invasion: - Present. Dermal Lymph-Vascular Invasion: SURGICAL PATHOL Report. - Not identified. Lymph Nodes: - Number of sentinel lymph nodes examined: 2. - Total number of lymph nodes examined (sentinel and Nonsentinel): 10. - Number of lymph nodes with macrometastases (>0.2 cm): 2. Extranodal Extension: - Not identified. Method of Evaluation of Sentinel Lymph Nodes: - Hematoxylin and eosin (H&E, one level). - Immunohistochemistry. Anciliary Studies: Estrogen Receptor: - Performed on another specimen: Results: Immunoreactive tumor cells present (1%). Progesterone Receptor: - Performed on another specimen: Results: Immunoreactive tumor cells present (1%). HER2/neu. - Performed on another specimen: Results: Equivocal (Score 2+). CISH for HER2/Neu: - Performed on another specimen: Results: Not amplified (HER2 gene copy <4.0 or ratio <1.8). TNM Descriptors: - m (multiple foci of invasive carcinoma). Primary Tumor (invasive Carcinoma) (pT). pT4b. Regional Lymph Nodes (pN): - pN1a. Distant Metastasis (M): - Not applicable. Pathologic Staging (PTNM): mpT3, N1a, M-not applicable. NOTE: Some antibodies are analyse specific reagents (ASRs) validated by our laboratory. Thase ASRs are clinically indicators that do not require mn Thase clones are. IDS-ER, AgR 636-PR, 1485-HER2, H-II-EGFR. All inohistochemical stains are used with formalin or molecular fuxed, paraffin embedded tissue. Detection is by. The desults are read byt. pathologist as posirive or negative. As the attending pathologist, I attest that I: (i) Examined the relevant preparation(s). for the specimen(s): and (ii) Rendered the diagnosis(es). Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. A. SENTINEL NODE # 1 AXILLA CONTENT. immunohistochemistry for keratin stain is negative for metastatic carcinoma to the fymph node. C. SENTINEL NODE # 2 AXILLA COUNT. Immunohistochemistry for keratin stain is negative for metastatic carcinoma to the lymph node. SURGICAL PATHOL Report. Intraoperative Consultation. A. Sentinel node # 1 axilla content. a. frozen section: Touch prep: Negative for metastatic carcinoma. C. Sentinel node # 2 Axilla count. ind Touch prep: Negative for metastatic carcinoma. Clinical History: Lobular carcinoma. Operation Performed. Right breast total mastectomy; Possible axillary node dissection; Sentinel node biopsy. Pre Operative Diagnosis: Breast cancer. Specimen(s) Received: A: Sentinel node # 1 axilla content : B: Right breast (short stitch superior long stitch lateral). C: Sentinel node # 2 Axilla count. Gross Description: A. Received fresh is an ovoid pale tan tissue fragment, 1 x 1 x 0.2 cm. Bisected and submitted in toto in one cassette for. frozen section. B. Received is a right mastectomy specimen with axillary tail, 21 x 16 x 4 cm. The specimen is oriented with short suture-. superior margin and long suture-lateral margin. At the anterior aspect, there is a segment of skin 10 x 5.5 x 015 cm with. areola and nipple. The nipple is depressed. There is an ill defined tumor mass, 4 x 3 x 1 cm, located at both lower inferior. quadrants (outer and inner). There is a metallic cllp. At the upper inner quadrant, there is a second tumor mass, 1 x. 1. x. 0.5 cm present, close to the anterior margin. The rest of the breast presente faw hreast stroma and abundant yellow. adipose tissue. Representative portion of tissue was taken for the : Ten possible lymph nodes are. grossly identified and present at the axillary tail. Representative sections are submitted in nineteen cassettes as. follows: 1. Nipple. 2. Deep margin. 3&4. Tumor, lower outer quadrant. 5&6. Tumor, lower inner quadrant. 7. Middle line tumor. 8. Second mass, upper inner quadrant close to anterior margin. 9. Upper outer quadrant. 10&11. One entire lymph node, per block. 12-19. One lymph node bisected, per block. C. Received is an ovoid pale tan tissue fragment, 1.2 x 1 x 0.5 cm. Bisected and submitted in toto in one cassette for. frozen. section. F. Pathologic Interpretation: AMMENDMENT TO PATHOLOGIC TUMOR STAGING AND RESULTS OF HER2 BY CISH (. A. SENTINEL NODE NO.1 AXILLA CONTENT. - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. B. RIGHT BREAST (SHORT STITCH SUPERIOR LONG STITCH LATERAL): Invasive lobular carcinoma, intermediate nuclear grade, with formation of two dominant tumoral masses, 4.0 cm and. 1.0 cm. - The tumor invades the dermal skin. - Lymphovascular spaces invasion is identified. - Specimen margin is negative for tumor. - Metastatic carcinoma to two of eight lymph nodes (/2/8). C. SENTINEL NODE NO. 2 AXILLA COUNT 605 FS: - No malignancy seen in one lymph node (0/1). - Immunohistochemistry for keratin to follow. Tumor Summary: Specimen: - Total breast. Procedure: - Total mastectomy. Lymph Node Sampling: - Sentinel lymph node. - Axillary dissection. Specimen Integrity: - Single intact specimen. Specimen Size: - Greatest dimension: 21 cm. Additional dimension: 16 x 4 cm. Laterality: - Right. Tumor Site: - Lower outer quadrant. - Upper inner quadrant. - Lower inner quadrant. Tumor Size: - Greatest dimension of largest focus of invasion over 0.1 cm: 4 cm. - Additional dimensions: 1 x 1 cm. Tumor Focality: - Multiple focus of invasive carcinoma. Macroscopic and Microscopic Extent of tumor: - Skin: Satellite skin foci of invasive carcinoma are present. Lobular Carcinoma IN Situ (LCIS): - Present. Histologic Type: - Invasive lobular carcinoma. Histologic Grade: - Overall Grade: Grade 2. Margins: - Margins uninvolved by invasive carcinoma. Lymph-Vascular Invasion: - Present. Permal Lymph-Vascular Invasion: - Not identified. Lymph Nodes: - Number of sentinel lymph nodes examined: 2. Total number of lymph nodes examined (sentinel and Nonsentinel): 10. - Number of lymph nodes with macrometastases (>0.2 cm): 2. Extranodal Extension: - Not identified. Method of Evaluation of Sentinel Lymph Nodes: - Hematoxylin and eosin (H&E, one level). - Immunohistochemistry. Ancillary Studies: Estrogen Receptor: - Performed on another specimen: Results: Immunoreactive tumor cells present (1%). Progesterone Receptor: - Performed on another specimen: Results: Immunoreactive tumor cells present (>1%). HER2/neu. Performed on another specimen: Results: Equivocal (Score 2+). CISH for HER2/Neu: - Performed on another specimen: Results: Amplified (HER2 gene copy <4.0 or ratio <1.8). (amended. TNM Descriptors: m (multiple foci of invasive carcinoma). Primary Tumor (invasive Carcinoma) (pT). pT4b. Regional Lymph Nodes (pN): pN1a. Distant Metastasis (M): - Not applicable. Pathologic Staging (pTNM): mpT4b, N1a, M-not applicable (amended. SOIE: Nome autibades an specific reagente (ANR) by our These ASRs are mejul that the not require / DA approal. These clones are nwt. 1/15 ER 11.11 AGH All Inmical are word with formales or molec uku finel, paroffin instituted linve. Detection is A;. The results are nat by a. prithologiv is postitive or reguire. As the attending pathologist, / attest that I: (i) Examined the relevant preparation(s). for the specimen(s): and (ii) Rendered the diagnosis(es). Amendments. Amended: Reason: Revise/Update Tumor Staging. Case is amended to revise Pathologic Tumor Staging and update results of Her2 by CISH. Previous Signout Date: Procedures/Addenda. Addendum. Date Complete: Addendum Diagnosis. A. SENTINEL NODE # 1 AXILLA CONTENT. - Immunohistochemistry for keratin stain is negative for metastatic carcinoma to the lymph node. C. SENTINEL NODE # 2 AXILLA COUNT. - Immunohistochemistry for keratin stain IS negative for metastatic carcinoma to the lymph node. Intraoperative Consultation. A. Sentinel node # 1 axilla content. ? frozen section: Touch prep: Negative for metastatic carcinoma. C. Sentinel node # 2 Axilla count. and Touch prep: Negative for metastatic carcinoma. Clinical History: Lobular carcinoma. Operation Performed. Right breast total mastectomy; Possible axillary node dissection; Sentinel node biopsy. Pre Operative Diagnosis: Breast cancer. Specimen(s) Received: A: Sentinel node # 1 axilla content. B: Right breast (short stitch superior long stitch lateral). C: Sentinel node # 2 Axilla count. Gross Description: A. Received fresh is an ovoid pale tan tissue fragment, 1 X 1 x 0.2 cm. Bisected and submitted in toto in one cassette for. frozen section. B. Received is a right mastectomy specimen with axillary tail, 21 x 16 x 4 cm. The specimen is oriented with short suture-. superior margin and long suture-lateral margin. At the anterior aspect, there is a segment of skin 10 x 5,5 x 0,5 cm with. areola and nipple. The nipple is depressed. There is an ill defined tumor mass, 4 x 3 x 1 cm, located at both lower inferior. quadrants (outer and inner). There is a metallic clip. At the upper inner quadrant, there is a second tumor mass, 1 x 1 x. 0.5 cm present, close to the anterior margin. The rest of the breast presents few breast stroma and abundant yellow. adipose tissue. Representative portion of tissue was taken for the. Ten possible lymph nodes are. grossly identified and present at the axillary tail. Representative sections are submitted in nineteen cassettes as follows: 1. Nipple. 2. Deep margin. 3&4. Tumor, lower outer quadrant. 5&6. Tumor, lower inner quadrant. 7. Middle line tumor. 8. Second mass, upper inner quadrant close to anterior margin. 9. Upper outer quadrant. 10&11. One entire lymph node, per block. 12-19. One lymph node bisected, per block. C. Received is an ovoid pale tan tissue fragment, 1.2 x 1 x 0.5 cm. Bisected and submitted in toto in one cassette for frozen. section.

expanded version (tokens=3342) : 
 Here is a breakdown of the information in the breast pathology report:

1. Histological classification: 
- Subtype: Luminal A
- Invasive lobular carcinoma (ILC)
- Lobular Carcinoma IN Situ (LCIS)

2. Characteristics of the tumor:
- Intermediate nuclear grade
- Two dominant tumoral masses with sizes of 4.0 cm and 1.0 cm
- Invasion of dermal skin
- Presence of lymphovascular spaces invasion
- Negative tumor margin

3. Lymph node involvement:
- Sentinel node #1 axilla content: No malignancy detected (0/1)
- Sentinel node #2 axilla count: No malignancy detected (0/1)
- Metastatic carcinoma to two out of eight lymph nodes (2/8)

4. Ancillary testing results:
- Estrogen Receptor (ER) status: Immunoreactive tumor cells present (1%)
- Progesterone Receptor (PR) status: Immunoreactive tumor cells present (>1%)
- HER2/neu status: Equivocal result (Score 2+)
- CISH for HER2/Neu: Not amplified (HER2 gene copy <4.0 or ratio <1.8)

5. TNM staging:
- Primary Tumor (pT): pT4b (multiple foci of invasive carcinoma)
- Regional Lymph Nodes (pN): pN1a (met

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=3521) : 
 Pathology Report: Luminal A subtype. Right breast total mastectomy reveals invasive lobular carcinoma (ILC), intermediate nuclear grade. Two dominant tumoral masses measured 4.0 cm and 1.0 cm, with invasion of dermal skin and lymphovascular spaces. Skin satellite foci of invasive carcinoma present. Lobular Carcinoma IN Situ (LCIS) detected. ER and PR positive (1% and >1% respectively). HER2/neu status equivocal (Score 2+), with CISH showing no amplification. Metastatic carcinoma found in two out of eight lymph nodes examined (pN1a).

